Identification of sentinel lymph node in malignant melanoma by preoperative lymphoscintigraphy and intraoperative gamma probe guidance;Diagnostik des 'sentinel lymph node' bei malignem melanom: Praoperative lymphszintigraphie und intraoperative sondenmessung

NuklearMedizin

Volumn 37, Issue 5, 1998, Pages 177-182

  Dresel, S ^a   Weiss, M ^a   Heckmann, M ^a   Rossmuller B ^a   Konz, B ^a   Tatsch, K ^a   Hahn, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Gamma probe guidance; Lymphoscintigraphy; Malignant melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GAMMA RADIATION; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; TUMOR VOLUME; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTILLATION CAMERA; SCINTISCANNING; SKIN TUMOR;

DIAGNOSTIC AGENT; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M NANOCOLLOID;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GAMMA CAMERAS; HUMANS; INJECTIONS, INTRADERMAL; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RADIOPHARMACEUTICALS; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0032134463     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632328     Document Type: Article

References (29)

1. Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, Taylor AT. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997; 27: 55-67.
2. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS. Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-24.
3. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes Surg One 1993; 2: 137-43.
4. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg One 1993; 2: 303-8
5. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981; 193: 377-88.
6. Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. W J Surg 1992, 16: 214-21.
7. Fee HJ, Robinson DS, Sample WF, Graham LS, Holmes EC, Morton DL. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery 1978; 84: 626-32.
8. Glass LF. Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D. Fenske NA The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermat Surg 1996; 22: 715-20.
9. Hohenberger W, Gohl J. AltendorfHofmann A, Meyer T. Lymph node dissections in malignant melanoma. Chirurg 1996; 67: 779-87.
10. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654-60
11. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg One 1993; 2: 335-40.
12. Lamki LM, Logic JR. Defining lymphatic drainage patterns with cutaneous lymphoscintigraphy. In: Cutaneous Melanoma. Balch CM, Houghton AN. Philadelphia: JB Lippincott: 1992; 367-75.
13. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE, Jr., Morita ET, el-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666-73.
14. Lingam MK, Mackie RM, McKay AJ, Intraoperative identification of sentinel lymph node in patients with malignant melanoma. B J Cancer 1997; 75: 1505-8.
15. Messina JL, Glass LF. Pathologic examination of the sentinel lymph node. J Florida Med Ass 1997; 84: 153-6.
16. Meyer CM, Lecklitner ML, Logic JR, Balch CE, Bessey PQ, Tauxe WN. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology 1979; 131: 205-209.
17. Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg 1982; 69: 108-11.
18. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993; 11: 1751-6.
19. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage mela-noma. Arch Surg 1992; 127: 392-9.
20. Mudun A, Murray DR, Herda SC, Eshima D, Shattuck LA, Vansant JP, Taylor AT, Alazraki NP. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-5.
21. Reinigen D, Balch CM, Kirkwood J, Ross M, Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997; 225: 1-14.
22. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G. et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220 (6): 759-67.
23. Reintgen DS, Cox EB, McCarty KS Jr., Vollmer RT, Seigler HF. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983; 198: 379-85.
24. Ross ML, Reintgen DS, F. M. B. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993; 9: 219-23.
25. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 1978; 41: 948-56.
26. Singh K, Sardi A, Conaway G, Spiegler E. Use of gamma detecting probe and isosulphan blue to localize sentinel node in patients with malignant melanoma. Maryland Med J 1996; 45: 476-81.
27. Sullivan DC, Croker BP, Jr., Harris CC, Deery P, Seigler HF. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid. Am J Roent 1981; 137: 847-51.
28. Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorskj VV, Kirov S, Kulakowski A, Lacoub J, Lejeune F, Mechl Z, Morabito A, Rode I, Sergeev S, van Slooten E, Szcygiel K, Trapeznikov NN. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977; 297: 627-30.
29. Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorski VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Mechl Z, Morabito A, Rode I, Sergeev S, van Slooten E, Szczygiel K, Trapeznikov NN, Wagner RI. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982; 49: 2420-30.